General Information

Specimen Collection and Test Updates – May 2024

The following information was updated in the Lab Catalog.

All changes are for Corewell Health Laboratories West.

 

Test Updates

New Tests

  • Biliary Tract Malignancy by FISH [LAB1231756]
  • Cytokine Panel 13, Plasma [LAB1230635]

Specimen Collection Updated

  • TB Screen (Quantiferon Gold) [LAB3619]
  • APTT DTI is now performable at Corewell Health Blodgett, Big Rapids, Gerber, Greenville, Ludington, Pennock, Reed City, and Zeeland hospitals.
  • Urine Eosinophilic [LAB10167] was rerouted from Corewell Health Zeeland and Greenville hospitals to Corewell Health Reference Laboratory, West (35 Michigan, Grand Rapids)
  • Gentamycin testing was rerouted from Zeeland Hospital to Corewell Health Reference Laboratory, West (35 Michigan, Grand Rapids)
  • The following body fluid tests were updated from collection in a green or red top tube to a clear tube, no additive.
    • Creatinine, Body Fluid [LAB184]
    • Triglycerides, Body Fluid [LAB200]
    • Lactate Dehydrogenase (LDH), Body Fluid (Non-CSF) [LAB188]
    • Albumin, Body Fluid [LAB177]
    • Amylase, Body Fluid [LAB178]
    • Glucose, Body Fluid [LAB186]
    • Protein, Body Fluid [LAB196]

Document Updates

 


EMR/LIS Updates (eSHare or EHR Interface):

The following lab tests have updated information for interfaced clients (non-Corewell Health/Independent Outpatient offices or not on Corewell Health EPIC) with Corewell Health Laboratories. If you did not receive the file definition via email, please contact your vendor, the PRAS Team or use the Contact Us link above.

If you require a file definition or compendium for your EMR please use the “Contact Us” link above.

FAQ for Orders and Results Interface

  • NEW: Biliary Tract Malignancy by FISH [1231756]
  • Discontinued: Histoplasma Antibody Serum [11271] replace with Histoplasma Antibody Complement Fixation and Immunodiffusion, Serum [1231760]

 


All specimen collection updates

Previous Post

You Might Also Like

No Comments

Leave a Reply